Interaction of SSR161421, a novel specific adenosine A3 receptor antagonist with adenosine A3 receptor agonists both in vitro and in vivo-Reference-Cited by-同舟云学术

Interaction of SSR161421, a novel specific adenosine A3 receptor antagonist with adenosine A3 receptor agonists both in vitro and in vivo

Published:2013-01 Issue:1-3 Volume:699 Page:62-66
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Mikus Endre G.,Boér Kinga,Timári Géza,Urbán-Szabó Katalin,Kapui Zoltán,Szeredi Judit,Gerber Katalin,Szabó Tibor,Bátori Sándor,Finet Michel,Arányi Péter,Galzin Anne-Marie

Publisher

Elsevier BV

Subject

Pharmacology

Reference15 articles.

1. Isolated bronchi from asthmatics are hyperresponsive to adenosine, which apparently acts indirectly by liberation of leukotrienes and histamine;Björck;Am. Rev. Respir. Dis.,1992

2. Functional characterization of the A2B adenosine receptor in NIH 3T3 fibroblasts;Brackett;Biochem. Pharmacol.,1994

3. Relationship between the inhibition constant (KI), and the concentration of inhibitor which causes 50 per cent inhibition (I50), of an enzymatic reaction;Cheng;Biochem. Pharmacol.,1974

4. Studies on the receptor mediating cyclic AMP-independent enhancement by adenosine of IgE-dependent mediator release from rat mast cells;Church;Br. J. Pharmacol.,1986

5. Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects;Cushley;Br. J. Clin. Pharmacol.,1983

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A3 Adenosine Receptor Ligands: From Discovery to Clinical Trials;Topics in Medicinal Chemistry;2023

2. Reduction in murine acute GVHD severity by human gingival tissue-derived mesenchymal stem cells via the CD39 pathways;Cell Death & Disease;2019-01

3. Evaluation of SSR161421, a novel orally active adenosine A3 receptor antagonist on pharmacology models;European Journal of Pharmacology;2013-01